CERVINO has 46 mg of Dex in week one! so Toci proph and Dex 10 mg on SUD and 36 mg with full dose. I do think with higher doses of Dex we see less CRS but i would rather have grade 1 CRS in my older patient than Dex associated delirium.

“An Unexpected Benefit of Adding the Patient Voice to Medical Education - Train Providers to be Better” sciencedirect.com/science/ar… Amyloidosis is a complex multi-systemic disease. Lack of knowledge about amyloidosis and subsequent mis- or under-diagnosis are major obstacles to treatment, which result in life-threatening organ damage, heart failure, morbidity, and mortality. At present, medical didactic education about amyloidosis leaves new physicians woefully unprepared to suspect and diagnose amyloidosis. A study published in 2023 confirmed a positive impact on medical students following a patient presentation. Continued analysis of the study data revealed an unexpected benefit of adding the patient voice to medical education. The purpose of this paper is to describe this unexpected and potentially powerful benefit. -- Thank you to Dr. Arvind Bhimaraj for his unwavering support for our work and the importance of including the patient voice in medical education.

For older pts who do not tolerate dex, is anyone reducing the dex empirically during sud and full dosing with BsAb? In many MM trials if you’re > 75, dex is 20 mg/wk, but with BsAb, it can be a high 40-50 mg/wk during step up… i’m seeing more dex related problems than BsAb…

Happy Halloween from Red, your favorite Hemo-GOBLIN! 👹🩸🎃

If you stop Revlimid maintenance and your numbers rise, can you go back on it before it becomes a full relapse? IMF NLB member Sam Shenoy breaks down what it depends on in this short clip. #AsktheIMF @Bethfaiman

This will be one of the significant challenges if our care moves that direction. Another - and one that I think about frequently - is the question of who does the work. Who responds to this influx of data? Relatedly, who carries liability for decisions when data flow becomes “metronomic” (my term, maybe not the best description). I think health systems have a lot of unglamorous work to do around systems and infrastructure in the next 2-5 years.

Here’s the latest @JADPRO issue! Some great papers included, and I comment on #burnout and #resilience in #oncology! @APSHOorg

Episode 2 just dropped! How do you envision #AI fitting into #clinicaltrials? Hear what experts @RahulBanerjeeMD and @LouisWilliamsMD have to say! 👉👉 podcasts.apple.com/us/podcas…

What Is a Clonality ID in Multiple Myeloma? How Is It Used for MRD Testing? piped.video/hl9JRKySz5o #mmsm @DrOlaLandgren

Global Myeloma Experts Define Cure for a Disease Long Considered Incurable - @TheIACH @ComyCongress myelomasociety.org/ims-news-…

This was a fun one! All important points to consider with #CART. Have a listen if interested! Thanks @OncBrothers for having us!! @OncUpdates @Rfonsi1

Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma - ENDURANCE [Jul 15, 2026] @myelomaMD et al. @VincentRK @NEJM nejm.org/doi/full/10.1056/NE… #NCT01863550 #mmsm @eaonc E1A11

New publication 📝 The BRIDGE-2M consensus, published in @AdvancesTherapy, links five patient-specific attributes to individualized bridging therapy objectives for patients with RRMM awaiting CAR T-cell therapy. Learn more about RRMM: multiplemyelomahub.com/types… #MultipleMyeloma #myeloma #mmsm #MedEd @RahulBanerjeeMD

Really enjoyed sitting down with @RahulBanerjeeMD and @Blood_Cancers to discuss our approach to #AI across the @ClevelandClinic cancer service line and the tremendous potential for emerging models across #hematology more broadly. @jamecancerdoc @CleClinicMD #mmsm bloodcancerstoday.com/podcas…

Join us for the upcoming IACH Multiple Myeloma Masterclass Series: 𝗖𝗔𝗥-𝗧: 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗶𝗻𝗴 𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝗻𝗱 𝗘𝗮𝗿𝗹𝘆 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗲 with Rahul Banerjee Tuesday, November 3 6 pm CET • 12 pm NY Register now for free👇 us06web.zoom.us/webinar/regi… @RahulBanerjeeMD @Mohty_EBMT

Join us for the Philip R. Greipp, MD Mayo Clinic Patient Symposium on Multiple Myeloma, AL Amyloidosis & Waldenström Macroglobulinemia. 📅 Oct. 31, 2026 📍 Eagan, MN + limited virtual option (QR code below) 🎟️ Free registration Learn. Connect. Ask questions. Find support. @Myeloma_mSMART @MyelomaDrKapoor @VincentRK @ADispenzieri @IMFnurseMyeloma @Taxkourel @RahmaWarsameMD #MultipleMyeloma #Amyloidosis #Waldenstrom

Very important work. 👏👏 I have tended to use IVIg more liberally in patients on Dara, especially for winter months. 29% grade 3 infection rates are in the realm of TRIMM-2 and MonumenTAL-1!

Wait- you will be speaking at the @IMFmyeloma workshop? I will be speaking, too! Please join us virtually!! @jmikhaelmd

AbbVie Submits Biologics License Application (BLA) for Etentamig to U.S. FDA for Adults ... - goo.gl/alerts/rMPTwY #GoogleAlerts

Update: We did it!! For 🇺🇸 pts with myeloma, Medicare coverage for transplant is safe and sound. No more exclusion of Stage I #MMsm or CKD! Thanks to all who submitted comments; 👏 @AJPortuguese for govt testimony with help from @ASTCT and @ASH_hematology. Advocacy works!